Cancer Research UK Manchester Centre

Recent papers from Cancer Research UK Manchester Centre

1. Recovering anaerobic bacterial genomes in saliva, tumour and blood whole genome sequencing data from patients with prostate cancernpj Biofilms and Microbiomes · 2026
2. The molecular heterogeneity and clinical impact of genomic driver alterations in prostate cancerNature Communications · 2026
3. Examining the role of extrachromosomal DNA in lung cancerJNCI Journal of the National Cancer Institute · 2026
4. X-Ray Exposure Induces Structural Changes in Human Breast ProteinsInternational Journal of Molecular Sciences · 2025
5. Prostate cancer clinicopathological presentation in South-East Africa during the 2010 decadeJNCI Journal of the National Cancer Institute · 2025
6. Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinomaNature Medicine · 2025
7. Longitudinal Follow-Up of the Psychological Well-Being of Patients with Colorectal Cancer: Final Analysis of PICO-SMCurrent Oncology · 2024
8. Waist circumference-years and cancer risk: a prospective study of the association and comparison of predictive performance with waist circumference and body mass indexBritish Journal of Cancer · 2024
9. Clonal evolutionary analysis reveals patterns of malignant transformation in pancreatic cancer from Intraductal Papillary Mucinous IPMN Neoplasms (IPMN)2024
10. The PI3Kδ inhibitor zandelisib on intermittent dosing in relapsed/refractory follicular lymphoma: Results from a global phase 2 studyHemaSphere · 2024
11. Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doublingNature Communications · 2024
12. Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft modelsNature Communications · 2024
13. A novel preclinical model of the normal human breastJournal of Mammary Gland Biology and Neoplasia · 2024
14. AmplificationTimeR: An R Package for Timing Sequential Amplification EventsBioinformatics · 2024
15. Abstract 5071: Minimal residual disease (MRD) status by peripheral blood mononuclear cells (PBMCs) and circulating tumor DNA (ctDNA) demonstrates rapid, deep, and sustained response in patients (Pts) with relapsed/refractory follicular lymphoma (R/R FL) treated with subcutaneous (SC) epcoritamab monotherapy in the pivotal phase 1/2 EPCORE™ NHL-1 trialCancer Research · 2024
16. Abstract 3732: Peripheral pharmacodynamic activity of epcoritamab as monotherapy and in combination with rituximab + lenalidomide in patients with follicular lymphomaCancer Research · 2024
17. The MARECA (national study of management of breast cancer locoregional recurrence and oncological outcomes) study: protocol for a prospective, multicentre cohort studyInternational Journal of Surgery Protocols · 2024
18. The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinomaNature Cancer · 2024
19. Overweight‐years and cancer risk: A prospective study of the association and comparison of predictive performance with body mass index (Atherosclerosis Risk in Communities Study)International Journal of Cancer · 2023
20. Pilot study of lung cancer screening for survivors of Hodgkin lymphomaHaematologica · 2023